Development of an In Vitro Biopotency Assay for an AAV8 Hemophilia B Gene Therapy Vector Suitable for Clinical Product Release.
- DOI
- 10.1016/j.omtm.2020.03.013
- Published
- 2020 Jun 12
- Container
- Molecular therapy. Methods & clinical development
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.omtm.2020.03.013,
title = {Development of an In Vitro Biopotency Assay for an AAV8 Hemophilia B Gene Therapy Vector Suitable for Clinical Product Release.},
author = {Lengler J and Coulibaly S and Gruber B and Ilk R and Mayrhofer J and Scheiflinger F and Hoellriegl W and Falkner FG and Rottensteiner H},
year = {2020},
journal = {Molecular therapy. Methods \& clinical development},
doi = {10.1016/j.omtm.2020.03.013},
url = {https://doi.org/10.1016/j.omtm.2020.03.013}
}RIS
TY - JOUR TI - Development of an In Vitro Biopotency Assay for an AAV8 Hemophilia B Gene Therapy Vector Suitable for Clinical Product Release. AU - Lengler J AU - Coulibaly S AU - Gruber B AU - Ilk R AU - Mayrhofer J AU - Scheiflinger F AU - Hoellriegl W AU - Falkner FG AU - Rottensteiner H PY - 2020 JO - Molecular therapy. Methods & clinical development DO - 10.1016/j.omtm.2020.03.013 UR - https://doi.org/10.1016/j.omtm.2020.03.013 ER -
APA
J, L., S, C., B, G., R, I., J, M., F, S., W, H., FG, F., & H, R. (2020). Development of an In Vitro Biopotency Assay for an AAV8 Hemophilia B Gene Therapy Vector Suitable for Clinical Product Release.. Molecular therapy. Methods & clinical development. https://doi.org/10.1016/j.omtm.2020.03.013
Source records
- pubmed · retrieved 2026-09-27T15:28:30.999Z
- europe-pmc · retrieved 2026-09-27T15:28:31.025Z
- doaj · retrieved 2026-09-27T15:28:31.000Z